Toggle menu

ExPRES SEPSIS

Start date:
January 2014
End date:
July 2015
Co-ordinated by:
University of Edinburgh & NHS Lothian

Early Prediction of Severe Sepsis

Aim

To derive a biomarker to allow the identification of patients with confirmed sepsis, and risk stratify patients at risk of developing severe sepsis

Trial Design

A Prospective, multi-centre cohort observational study

Chief Investigator

Professor Tim Walsh, Critical Care Research Group

Local PI

Professor Tim Walsh

Research Team

  • EMERGE Research team
  • Critical Care Research Group
  • Rossi Lab, MRC Centre for Inflammation Research, Queens Medical Research Institute, University of Edinburgh

Eligibility criteria (summary)

Patients who present to the Emergency Department with suspected sepsis

Further information

http://www.ccm.mvm.ed.ac.uk/

http://www.cir.ed.ac.uk/

Research Team

Dr Deepankar Datta

Specialist Trainee Emergency Medicine

Julia Grahamslaw

Lead Research Nurse

Related news

Dip Dazzles at RCEM

Dip Dazzles at RCEM

9 Oct 2015 | Rachel O'Brien

Read more

More EMERGE Trials

CERA

COVID-19 Emergency Response Assessment. A Professional Survey

ISARIC4C – Coronavirus Clinical Characterisation Consortium, an observational study

ISARIC/WHO Clinical Characterisation Protocol for Severe Emerging Infections in the UK (CCP-UK)